PURCHASE, NY, October 31, 2005 -- Nutrition 21, Inc., (NASDAQ: NXXI) today announced a supply & licensing agreement with CNS, Inc, the Breathe Right® * company, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product in the FiberChoice® * franchise – FiberChoice Weight Management™ * chewable tablets. The product dosage will include 4 grams of fiber, 200 mcg of chromium as Chromax chromium picolinate, and green tea.
“The significant body of scientific evidence supporting Chromax chromium picolinate opened the door to a strategic collaboration with CNS, a company with solid experience in marketing self-care products for the wellness sector,” said Gail Montgomery, president and CEO, Nutrition 21. “Several major consumer product companies have already opted to include Chromax as an active ingredient in functional food products. However, CNS is the first to actively promote the functional benefits of Chromax to enhance the health benefits of a fiber product.”
Nutrition 21 has been the driving force behind chromium science and licenses chromium picolinate for its patented nutritional uses to vitamin, supplement and food marketers.
About Nutrition 21
Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The company markets Chromax chromium picolinate, http://www.chromax.com/, which is the most-studied form of the essential mineral chromium. Nutrition 21 also developed Diachrome®, which is available through diabetes educators or at http://www.diachrome.com. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at http://www.nutrition21.com
* Breathe Right®, FiberChoice® and FiberChoice Weight Management™ are trademarks of CNS, Inc.
About CNS, Inc.
CNS, based in Minneapolis, designs and markets consumer health care products, including Breathe Right® nasal strips and FiberChoice® dietary fiber supplements. The company focuses on products that address important consumer needs within the aging well/self care market, including better breathing and digestive health. Its common stock is listed on the Nasdaq National Market under the ticker symbol "CNXS." More information about CNS and its products is available at www.cns.com